Direct interaction between cancer cells and fibroblasts promotes early chemoresistance to standard-of-care drug therapy in small cell lung cancer (SCLC)

Nilu Dhungel, Brian Latimer, David Custis, Ana-Maria Dragoi

Open source

DOI
10.64898/2026.04.27.721078
Published
2026-04-30
Container
Not recorded
Publisher
openRxiv
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.04.27.721078,
  title = {Direct interaction between cancer cells and fibroblasts promotes early chemoresistance to standard-of-care drug therapy in small cell lung cancer (SCLC)},
  author = {Nilu Dhungel and Brian Latimer and David Custis and Ana-Maria Dragoi},
  year = {2026},
  doi = {10.64898/2026.04.27.721078},
  url = {https://doi.org/10.64898/2026.04.27.721078}
}

RIS

TY  - JOUR
TI  - Direct interaction between cancer cells and fibroblasts promotes early chemoresistance to standard-of-care drug therapy in small cell lung cancer (SCLC)
AU  - Nilu Dhungel
AU  - Brian Latimer
AU  - David Custis
AU  - Ana-Maria Dragoi
PY  - 2026
DO  - 10.64898/2026.04.27.721078
UR  - https://doi.org/10.64898/2026.04.27.721078
ER  - 

APA

Dhungel, N., Latimer, B., Custis, D., & Dragoi, A. (2026). Direct interaction between cancer cells and fibroblasts promotes early chemoresistance to standard-of-care drug therapy in small cell lung cancer (SCLC). https://doi.org/10.64898/2026.04.27.721078

Source records